CRSP Stock Price | CRISPR Therapeutics AG Stock Quote (U.S.: Nasdaq) | MarketWatch

Best Incense Sticks Collections

CRISPR Therapeutics AG

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

Source link

Salesforce Development Company